• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全基因组关联研究提示冠心病患者染色体 10rs139401390 对肾功能的影响。

Genome-wide association study suggests impact of chromosome 10 rs139401390 on kidney function in patients with coronary artery disease.

机构信息

Institute of Sports Medicine, Molecular Genetics of Cardiovascular Disease, University Hospital Muenster, Muenster, Germany.

Medical Clinic V, Mannheim Medical Faculty, University of Heidelberg, Mannheim, Germany.

出版信息

Sci Rep. 2019 Feb 26;9(1):2750. doi: 10.1038/s41598-019-39055-y.

DOI:10.1038/s41598-019-39055-y
PMID:30809046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6391429/
Abstract

Chronic kidney disease (CKD) is an independent risk factor for onset and progression of coronary artery disease (CAD). Discovery of predisposing loci for kidney function in CAD patients was performed using a genome-wide association approach. Inclusion criteria were CAD with ≥50% stenosis (≥1 coronary artery) and a creatinine-based estimated glomerular filtration rate (eGFR) of 30-75 ml/min/1.73 m. An association of rs139401390 located to a region 58.8 kb upstream of renalase (RNLS) with eGFR was detected in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study (n = 499, p = 7.88 × 10, mean eGFR 60.7 ml/min/1.73 m). Direct genotyping of rs139401390A > G suggested increased eGFR by 12.0 ml/min/1.73 m per A allele (p = 0.000004). Genome-wide replication of rs139401390A > G in the Coronary Artery Disease and Renal Failure (CAD-REF) registry with a mean eGFR of 47.8 ml/min/1.73 m (n = 574, p = 0.033) was only nominally significant. Comparison of rs139401390 genotypes for risk of reduced kidney function in the overall LURIC study revealed higher adjusted odds ratios (OR) for eGFR <60 ml/min/1.73 m for CAD patients (n = 1992, OR = 2.36, p = 0.008, G/A + G/G vs A/A) compared to patients with/without CAD (n = 2908, OR = 1.97, p = 0.014, G/A + G/G vs A/A). No significant risk elevation was detected in patients without CAD (n = 948, p = 0.571). rs139401390 may affect kidney function in CAD patients with mild reduction in eGFR.

摘要

慢性肾脏病 (CKD) 是冠状动脉疾病 (CAD) 发病和进展的独立危险因素。使用全基因组关联方法发现 CAD 患者肾功能易感性基因座。纳入标准为≥50%狭窄(≥1 支冠状动脉)的 CAD 和基于肌酐的估算肾小球滤过率(eGFR)为 30-75ml/min/1.73m。在路德维希港风险和心血管健康 (LURIC) 研究中,发现位于肾酶 (RNLS) 上游 58.8kb 处的 rs139401390 与 eGFR 相关(n=499,p=7.88×10,平均 eGFR 为 60.7ml/min/1.73m)。rs139401390A>G 的直接基因分型表明,每个 A 等位基因使 eGFR 增加 12.0ml/min/1.73m(p=0.000004)。在平均 eGFR 为 47.8ml/min/1.73m 的冠状动脉疾病和肾衰竭 (CAD-REF) 登记处进行的全基因组 rs139401390A>G 复制,p=0.033,仅具有名义显著性。在整个 LURIC 研究中,比较 rs139401390 基因型对肾功能下降风险的影响发现,对于 eGFR<60ml/min/1.73m 的 CAD 患者(n=1992,OR=2.36,p=0.008,G/A+G/G 与 A/A),调整后的比值比(OR)更高与有/无 CAD 的患者(n=2908,OR=1.97,p=0.014,G/A+G/G 与 A/A)相比。在无 CAD 的患者中未发现显著的风险升高(n=948,p=0.571)。rs139401390 可能会影响 eGFR 轻度降低的 CAD 患者的肾功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80e3/6391429/eff4d16b9761/41598_2019_39055_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80e3/6391429/9d845759a94d/41598_2019_39055_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80e3/6391429/eff4d16b9761/41598_2019_39055_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80e3/6391429/9d845759a94d/41598_2019_39055_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80e3/6391429/eff4d16b9761/41598_2019_39055_Fig2_HTML.jpg

相似文献

1
Genome-wide association study suggests impact of chromosome 10 rs139401390 on kidney function in patients with coronary artery disease.全基因组关联研究提示冠心病患者染色体 10rs139401390 对肾功能的影响。
Sci Rep. 2019 Feb 26;9(1):2750. doi: 10.1038/s41598-019-39055-y.
2
Association of renal function, estimated by four equations, with coronary artery disease.通过四个公式估算的肾功能与冠状动脉疾病的关联。
Int Urol Nephrol. 2015 Apr;47(4):663-71. doi: 10.1007/s11255-015-0935-y. Epub 2015 Mar 7.
3
Differential Impact of Chronic Kidney Disease on Coronary Calcification and Atherosclerosis in Asymptomatic Individuals with or without Diabetes: Analysis from a Coronary Computed Tomographic Angiography Registry.慢性肾脏病对无症状糖尿病及非糖尿病个体冠状动脉钙化和动脉粥样硬化的影响差异:来自冠状动脉 CT 血管造影登记研究的分析。
Cardiorenal Med. 2018;8(3):228-236. doi: 10.1159/000489097. Epub 2018 Jun 29.
4
Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9.非糖尿病合并冠心病患者的肾脏疾病进展:循环基质金属蛋白酶-2、-3 和-9 的预测作用。
PLoS One. 2013 Jul 26;8(7):e70132. doi: 10.1371/journal.pone.0070132. Print 2013.
5
Cardiac valve calcification is associated with presence and severity of coronary artery disease in patients with pre-dialysis chronic kidney disease.心脏瓣膜钙化与透析前慢性肾病患者冠状动脉疾病的存在及严重程度相关。
Clin Exp Nephrol. 2015 Dec;19(6):1090-7. doi: 10.1007/s10157-015-1104-4. Epub 2015 Mar 12.
6
Chronic kidney disease as a predictor of coronary lesion morphology.慢性肾脏病作为冠状动脉病变形态的预测因子。
Angiology. 2010 May;61(4):344-9. doi: 10.1177/0003319709351875. Epub 2009 Nov 24.
7
Severity of coronary artery disease is an independent risk factor for decline in kidney function.冠状动脉疾病的严重程度是肾功能下降的独立危险因素。
Eur J Intern Med. 2016 Sep;33:93-7. doi: 10.1016/j.ejim.2016.06.031. Epub 2016 Jul 9.
8
Relationship between renal dysfunction and severity of coronary artery disease in Japanese patients.肾功能与日本患者冠状动脉疾病严重程度的关系。
Circ J. 2010 Apr;74(4):786-91. doi: 10.1253/circj.cj-09-0715. Epub 2010 Feb 17.
9
High plasma chemerin is associated with renal dysfunction and predictive for cardiovascular events - Insights from phenotype and genotype characterization.高血浆chemerin与肾功能不全相关且可预测心血管事件——来自表型和基因型特征分析的见解
Vascul Pharmacol. 2016 Feb;77:60-8. doi: 10.1016/j.vph.2015.08.010. Epub 2015 Aug 21.
10
Evaluation of a genetic risk score based on creatinine-estimated glomerular filtration rate and its association with kidney outcomes.基于肌酐估算肾小球滤过率的遗传风险评分评估及其与肾脏结局的关系。
Nephrol Dial Transplant. 2018 Oct 1;33(10):1757-1764. doi: 10.1093/ndt/gfx337.

引用本文的文献

1
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据:美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
2
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.2024 年心脏病与中风统计数据:美国心脏协会发布的美国和全球数据报告。
Circulation. 2024 Feb 20;149(8):e347-e913. doi: 10.1161/CIR.0000000000001209. Epub 2024 Jan 24.
3
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.

本文引用的文献

1
Synergistic effect of renalase and chronic kidney disease on endothelin-1 in patients with coronary artery disease ‒ a cross-sectional study.肾酶与慢性肾脏病对冠心病患者内皮素-1的协同作用——一项横断面研究。
Sci Rep. 2018 May 9;8(1):7378. doi: 10.1038/s41598-018-25763-4.
2
Two-year outcome and risk factors for mortality in patients with coronary artery disease and renal failure: The prospective, observational CAD-REF Registry.冠心病合并肾衰竭患者的两年预后及死亡风险因素:前瞻性观察性CAD-REF注册研究
Int J Cardiol. 2017 Sep 15;243:65-72. doi: 10.1016/j.ijcard.2017.05.022. Epub 2017 May 7.
3
1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function.
《心脏病与卒中统计数据-2023 更新:美国心脏协会报告》。
Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25.
基于 1000 基因组的荟萃分析确定了 10 个与肾功能相关的新位点。
Sci Rep. 2017 Apr 28;7:45040. doi: 10.1038/srep45040.
4
Extracellular renalase protects cells and organs by outside-in signalling.细胞外肾酶通过由外向内的信号传导保护细胞和器官。
J Cell Mol Med. 2017 Jul;21(7):1260-1265. doi: 10.1111/jcmm.13062. Epub 2017 Feb 26.
5
Plasma renalase in chronic kidney disease: differences and similarities between humans and rats.慢性肾脏病中的血浆肾酶:人与大鼠的差异与相似之处
Curr Hypertens Rev. 2014;10(3):166-70. doi: 10.2174/1573402111666150108101709.
6
Genome-wide association study of kidney function decline in individuals of European descent.欧洲血统个体肾功能下降的全基因组关联研究。
Kidney Int. 2015 May;87(5):1017-29. doi: 10.1038/ki.2014.361. Epub 2014 Dec 10.
7
Renalase prevents AKI independent of amine oxidase activity.肾酶可独立于胺氧化酶活性预防 AKI。
J Am Soc Nephrol. 2014 Jun;25(6):1226-35. doi: 10.1681/ASN.2013060665. Epub 2014 Feb 7.
8
Renalase in hypertension and kidney disease.肾酶与高血压及肾脏疾病。
Nephrol Dial Transplant. 2014 Jan;29(1):22-8. doi: 10.1093/ndt/gft083. Epub 2013 Oct 17.
9
The Coronary Artery Disease and Renal Failure (CAD-REF) registry: trial design, methods, and aims.冠状动脉疾病和肾衰竭(CAD-REF)登记研究:试验设计、方法和目的。
Am Heart J. 2013 Sep;166(3):449-56. doi: 10.1016/j.ahj.2013.06.010. Epub 2013 Jul 23.
10
Overlap between common genetic polymorphisms underpinning kidney traits and cardiovascular disease phenotypes: the CKDGen consortium.常见的遗传多态性在肾脏特征和心血管疾病表型中存在重叠:CKDGen 联盟。
Am J Kidney Dis. 2013 Jun;61(6):889-98. doi: 10.1053/j.ajkd.2012.12.024. Epub 2013 Mar 6.